Another Th2 cell cytokine, IL-9, was elevated in patients staged 0-IV vs. control (Table 1), however, other reports showed decreased level of IL-9 in group staged I-IV CRC compared to controls [28]. The gene discussed is IL9; the disease is colorectal carcinoma.